Palopegteriparatide - NDC Database
3 records found
Page:
73362-100 Aug 09, 2024
Palopegteriparatide 168 ug/.56ml Subcutaneous Injection, Solution by Ascendis Pharma, Endocrinology, Inc.
Palopegteriparatide 168 ug/.56ml Subcutaneous Injection, Solution by Ascendis Pharma, Endocrinology, Inc.
73362-101 Aug 09, 2024
Palopegteriparatide 294 ug/.98ml Subcutaneous Injection, Solution by Ascendis Pharma, Endocrinology, Inc.
Palopegteriparatide 294 ug/.98ml Subcutaneous Injection, Solution by Ascendis Pharma, Endocrinology, Inc.
73362-102 Aug 09, 2024
Palopegteriparatide 420 ug/1.4ml Subcutaneous Injection, Solution by Ascendis Pharma, Endocrinology, Inc.
Palopegteriparatide 420 ug/1.4ml Subcutaneous Injection, Solution by Ascendis Pharma, Endocrinology, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.